Literature DB >> 35557584

Knockdown of tankyrase 1 inhibits the progression of gastric adenocarcinoma via regulating human telomerase reverse transcriptase and telomeric repeat binding factor 1.

Wei Liu1, Ji-Jun Zhu1, Yun-Yun Liu1, Na-Na Tang1, Yan Wang1, Bo Jiang1, Li-Li Wang1, Yu-Xin Wang1, Min-Peng Xie1, Xiao-Yan Wang1.   

Abstract

Background: Gastric cancer is one of the most lethal cancers. Aberrant expression levels of genes are frequently associated with cell immortalization and the occurrence of tumors. In this study, we aimed to investigate the role of tankyrase 1 (TANK1) in gastric adenocarcinoma and clarify the underlying mechanism.
Methods: The messenger RNA (mRNA) levels of TANK1, human telomerase reverse transcriptase (h-TERT), and telomeric repeat binding factor 1 (TRF1) in clinical specimens and SGC-7901 cells were measured via real-time quantitative polymerase chain reaction (RT-qPCR). Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and immunohistochemistry (IHC) assays were utilized to observe the cell apoptosis as well as Ki67 and h-TERT expression in tumor-bearing models. The effects of TANK1 antisense oligonucleotides (TANK1 ASODN) on viability and apoptosis of SGC 7901 cells were evaluated by cell counting kit-8 and flow cytometry analysis.
Results: We found that TANK1 and h-TERT were both increased in gastric adenocarcinoma, while TRF1 was decreased. Tumor-bearing models demonstrated that TANK1 ASODN appeared to be effective in inhibiting tumor growth and decreasing the expression of h-TERT. Additionally, TANK1 ASODN inhibited the viability and promoted apoptosis of SGC-7901 cells. Moreover, the mRNA levels of h-TERT and TRF1 were modulated by TANK1 ASODN. Conclusions: This study revealed that TANK1 ASODN inhibits the proliferation and induced the apoptosis of gastric adenocarcinoma cells via manipulating the expression levels of h-TERT and TRF1. 2022 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Tankyrase 1 (TANK1); gastric adenocarcinoma; human telomerase reverse transcriptase (h-TERT); telomeric repeat binding factor 1 (TRF1)

Year:  2022        PMID: 35557584      PMCID: PMC9086053          DOI: 10.21037/jgo-22-82

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  32 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Telomerase: an RNP enzyme synthesizes DNA.

Authors:  Elizabeth H Blackburn; Kathleen Collins
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-05-01       Impact factor: 10.005

3.  IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.

Authors:  Sara R Martins-Neves; Daniela I Paiva-Oliveira; Carlos Fontes-Ribeiro; Judith V M G Bovée; Anne-Marie Cleton-Jansen; Célia M F Gomes
Journal:  Cancer Lett       Date:  2017-11-08       Impact factor: 8.679

4.  Tankyrase1-mediated poly(ADP-ribosyl)ation of TRF1 maintains cell survival after telomeric DNA damage.

Authors:  Lu Yang; Luxi Sun; Yaqun Teng; Hao Chen; Ying Gao; Arthur S Levine; Satoshi Nakajima; Li Lan
Journal:  Nucleic Acids Res       Date:  2017-04-20       Impact factor: 16.971

5.  THE STUDY OF THE EXPRESSION OF CDH1, KI67, P53 AND HER2 IN DIFFUSE GASTRIC CARCINOMA.

Authors:  T Muzashvili; A Tutisani; G Chabradze; N Beridze; N Museridze
Journal:  Georgian Med News       Date:  2020-02

6.  [Construction of antisense human tankyrase-1 RNA retroviral vector and its inhibition on tongue cancer cells].

Authors:  Yu-xin Ji; Ping Zhang; Wei-min Chen; Sheng-rong Zhu; Xue-jin Tao
Journal:  Zhonghua Kou Qiang Yi Xue Za Zhi       Date:  2007-03

7.  Tankyrase inhibition impairs directional migration and invasion of lung cancer cells by affecting microtubule dynamics and polarity signals.

Authors:  Barbara Lupo; Jorge Vialard; Francesco Sassi; Patrick Angibaud; Alberto Puliafito; Emanuela Pupo; Letizia Lanzetti; Paolo M Comoglio; Andrea Bertotti; Livio Trusolino
Journal:  BMC Biol       Date:  2016-01-19       Impact factor: 7.431

8.  Antisense oligonucleotide against hTERT (Cantide) inhibits tumor growth in an orthotopic primary hepatic lymphoma mouse model.

Authors:  Bo Yang; Rui-li Yu; Shuai Tuo; Chao-wei Tuo; Qiu-zhen Liu; Ning Zhang; Xue-chun Lu; Xiao-hua Chi; Shu-bao Lv; Li-li Cai
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

9.  XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway.

Authors:  Xiao-Hong Tian; Wei-Jian Hou; Yan Fang; Jun Fan; Hao Tong; Shu-Ling Bai; Qu Chen; He Xu; Yan Li
Journal:  J Exp Clin Cancer Res       Date:  2013-12-05

Review 10.  Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations.

Authors:  Hiroto Katoh; Shumpei Ishikawa
Journal:  J Hum Genet       Date:  2021-07-16       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.